Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers
Adel Alblihy(University of Nottingham), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Mashael Algethami(University of Nottingham), Juliette Servante(Royal Derby Hospital), Stephen Chan(Heidelberg University), Ahmed Shoqafi(University of Nottingham), Jennie N. Jeyapalan(University of Nottingham), Tarek M.A. Abdel-Fatah(University of Nottingham), Nigel P. Mongan(University of Nottingham), Anna E. Harris(University of Nottingham), Michael S. Toss(Nottingham City Hospital), Andrew R. Green(Nottingham Biomedical Research Centre), Emad A. Rakha(Nottingham University Hospitals NHS Trust)
Cited by 26
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer
|Journal of Clinical Oncology|1999|639